NP89
NOTICE OF ACCEPTANCE OF PARTIAL SEC. 8 & 9 EMAILED
18/01/2026
Voltar para busca
Dado oficial do USPTO
INDIVUMED
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
INDIVUMED
ST13
US500000078349885Classe
5, 9, 42, 44
Pedido
78349885
Registro
3007328
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
10/02/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 42, 44
Data de depósito
09/01/2004
Data de registro
18/10/2005
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/01/2026
Última transação
10/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
99
Localização do titular
Hamburg, DE
Examinador
LORENZO, ROBERT
Titulares e representantes
Titulares
Indivumed GmbH
Representantes
Tristram R. Fall, III FOX ROTHSCHILD LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and veterinary preparationsmedicines for humans and animals for the treatment of cancermetabolic diseasescardiovascular diseasesinflammatory diseasesdiseases of the immune system; human and animal sample materialallograft or xenograft tissue preparationstissue cutsblood plasmablood serum((ascites)) cerebrospinal fluidhuman and animal urine and human and animal stool; test kits for human and animal sample materialallograft or xenograft tissue preparationstissue cutsblood plasmablood serumascitescerebrospinal fluidhuman and animal urine and human and animal stool; diagnostic aids and therapeutic agentsin particular produced using molecular biologicalmolecular geneticgenetic engineeringimmunological and biotechnical methods for clinical and medical and laboratory use
Classe 9
Scientific apparatus and instrumentstissue punchespunch biopsybiopsy needlesapparatus for collecting biological samples such as tissuecutsbloodserumplasmaascitescerebrospinal fluidurine or stool; electronic apparatus and instruments for scientific laboratory researchelectronic analyzers and analyzers for the qualitative and quantitative recognition of samples and identification of the sample type; scientific electronic apparatus for the typing of tissues and tissue cuts; scientific electronic apparatus for collecting biological samples such as tissuecutsbloodserumplasmaascitescerebrospinal fluidurine or stool; scientific electronic apparatus for recordingtransmission and reproduction of data; magnetic data carriers; data-processors and computers
Classe 42
Scientific research; design and development of new technology for others in the field of cancermetabolic diseasescardiovascular diseasesinflammatory diseasesdiseases of the immune system; industrial design analysis and research services; design and development of computer hardware and software relating to programs for data processing; scientific research for medical purposes relating to molecular biologicalimmunological and histological laboratoryin particular research and development work in the field of human medicine and veterinary medicine diagnosis and treatment ; medical laboratoriestyping of tissues and tissue cutsin particular by means of molecular biologicalimmunologicalgenetic engineering and histological methods; laboratory blood testing services
Classe 44
(( Medical testing in connection with the treatment of individuals; X-ray services; medical clinic services ; medicinal counseling ))
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
18/01/2026
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
18/01/2026
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
18/01/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
18/01/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
13/10/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
18/10/2024
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/10/2015
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/10/2015
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/10/2015
E89R
TEAS SECTION 8 & 9 RECEIVED
30/09/2015
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
10/05/2012
NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
10/05/2012
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
10/05/2012
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
10/05/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/05/2012
8.AF
REGISTERED - SEC. 8 (6-YR) FILED
22/03/2012
E15R
TEAS SECTION 15 RECEIVED
22/03/2012
ES8R
TEAS SECTION 8 RECEIVED
22/03/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
18/10/2005
PUBO
PUBLISHED FOR OPPOSITION
26/07/2005
NPUB
NOTICE OF PUBLICATION
06/07/2005
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
31/03/2005
ALIE
ASSIGNED TO LIE
11/03/2005
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/03/2005
GNEA
EXAMINERS AMENDMENT E-MAILED
07/03/2005
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/03/2005
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/03/2005
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/02/2005
ALIE
ASSIGNED TO LIE
04/02/2005
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/02/2005
GNEA
EXAMINERS AMENDMENT E-MAILED
02/02/2005
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/02/2005
ACEC
AMENDMENT FROM APPLICANT ENTERED
13/01/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/11/2004
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/11/2004
GNRT
NON-FINAL ACTION E-MAILED
18/06/2004
DOCK
ASSIGNED TO EXAMINER
15/06/2004
NWAP
NEW APPLICATION ENTERED
14/01/2004
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace INDIVUMED ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.